| Structure | Chemical Name | CAS | MF |
|
BCM(R) MRSA 1.0 BASAL MEDIUM
|
|
|
|
|
BcnI (CauII)
|
|
|
|
|
BCM(R) O157:H7(+)
|
|
|
|
BD 1047 DIHYDROBROMIDE
|
138356-20-4
|
C13H20Cl2N2
|
|
BD 1008 Dihydrobromide
|
138356-09-9
|
C15H22Cl2N2
|
|
|
BCM(R) SHIGELLA 1.0 PLATING MEDIUM
|
|
|
|
BDCS, silylation reagent, AcroSeal
|
1185092-02-7
|
C9H19ClN2Si
|
|
|
7b-deacetyl-7b-(gamma-(morpholino)butyryl)forskolin
|
|
|
|
B-decachloro-1,2-dicarbadecaborane
|
18988-74-4
|
C2B10Cl10
|
|
B-DECALACTONE
|
|
|
|
1,2,3,4,6,7,8,9,10,10b-Decahydro-6,6-dimethylcyclopenta[a]quinolizine
|
73825-74-8
|
C14H23N
|
|
1,2,3,4,6,7,8,11,12,12b-Decahydrobenz[a]anthracene
|
16434-56-3
|
C18H22
|
|
1,3,4,6,7,8,9,10,11,11b-Decahydro-6,6-dimethyl-2H-benzo[a]quinolizine
|
73713-73-2
|
C15H25N
|
|
|
BCMV protocol
|
|
|
|
|
B834(DE3) COMPETENT CELLS
|
|
|
|
|
BBXNEFA
|
|
|
|
|
B834(DE3) COMP CELLS*
|
|
|
|
|
b-Defensin-4, human
|
|
|
|
|
b-Defensin-1, human
|
|
|
|
|
b-Defensin-3, human
|
|
|
|
|
B834(DE3) GLYCEROL STOCK*
|
|
|
|
|
BBXS
|
|
|
|
1-BCP
|
34023-62-6
|
C13H15NO3
|
|
BDF-8784
|
133408-47-6
|
C29H33N3O2
|
|
|
BDE 209 in 2,2,4-Trimethylpentane
|
|
|
|
|
BD FACS LYSING SOLUTION
|
|
|
|
|
BCNU, [CHLOROETHYL-2-14C]- 45-60 MCI(1.67-2.22 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 98% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
|
BD FACS RINSE
|
|
|
|
|
BD FACS CLEAN
|
|
|
|
|
BD FACS PERMEABILIZING SOLUTION 2
|
|
|
|
|
BCNT protein
|
|
|
|
|
BD FASTIMMUNE CD8/CD69/CD3
|
|
|
|
|
BD FASTIMMUNE ANTI-IFN-GAMMA/ANTI-IL-4
|
|
|
|
|
BD FASTIMMUNE ANTI-TNF-ALPHA/CD69/CD4
|
|
|
|
|
BD FASTIMMUNE CD69/CD3
|
|
|
|
|
BD FASTIMMUNE GAMMA2A/GAMMA1/CD4 ISOTYPE CONTROL
|
|
|
|
|
BD FASTIMMUNE GAMMA2A/GAMMA1 ISOTYPE CONTROL, FITC, PE
|
|
|
|
|
BD FASTIMMUNE GAMMA1/CD45 ISOTYPE CONTROL
|
|
|
|
|
BD FASTIMMUNE GAMMA2A/GAMMA1/CD8/CD3
|
|
|
|
|
BD FASTIMMUNE ANTI-IL-2/CD69/CD4
|
|
|
|
|
BD FASTIMMUNE ANTI-IFN-GAMMA/CD69/CD4
|
|
|
|
|
BD FASTIMMUNE CD63/CD123/ANTI-HLA-DR
|
|
|
|
|
BD FASTIMMUNE CD56/CD69/CD45
|
|
|
|
|
BD FASTIMMUNE GAMMA1/GAMMA1/CD3 ISOTYPE CONTROL
|
|
|
|
|
BD FASTIMMUNE CD2/CD2R
|
|
|
|
|
BD FASTIMMUNE CD4/CD69/CD3
|
|
|
|
|
BD FASTIMMUNE CD19/CD69/CD45
|
|
|
|
|
BD FASTIMMUNE GAMMA1/CD3 ISOTYPE CONTROL
|
|
|
|
|
BDELLIN
|
62494-89-7
|
|
|
|
bdellastasin
|
|
|
|
|
BCPC 1-benzyl-3-carboxyl pyridinium chloride
|
|
C13H12NO2
|
|
|
B27 COM, FLUORESCEIN, FITC CONJUGATE
|
|
|
|
|
BCOMM protocol
|
|
|
|
|
B.C.P.-Deoxycholate Agar
|
|
|
|
|
2B/3, Dengue Protease Substrate
|
|
|
|
|
BCPE protocol
|
|
|
|
|
B834(DE3)pLysS GLYCEROL STOCK*
|
|
|
|
|
B834(DE3)pLysS CC*
|
|
|
|
|
B834(DE3)PLYSS COMPETENT CELLS
|
|
|
|
|
B-CORE-APE-HSA
|
|
|
|
|
B-CORE-APE-HSA,GALA1-3GALSS1-O-APE-HSA
|
|
|
|
|
BDG
|
|
|
|
|
BCoR protein
|
|
|
|
|
BCPI-1 protein
|
|
|
|
b-D-Galactopyranoside, phenyl 2,3-bis-O-(phenylMethyl)-4,6-O-[(S)-phenylMethylene]-1-thio-
|
87470-72-2
|
C33H32O5S
|
|
b-D-Galactopyranoside, phenyl 3,4,6-tris-O-(phenylMethyl)-1-thio-
|
183875-29-8
|
C33H34O5S
|
|
b-D-Galactopyranose, 1-deoxy-2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethylene)-1-(phenylsulfonyl)-, (S)-
|
124477-10-7
|
C33H32O7S
|
|
|
b-D-Gal, 2-(2-Carboxyethylthio)-ethyl
|
|
|
|
|
b-D-GalNAc, 2-(2-Carboxyethylthio)-ethyl
|
|
|
|
B-D-GALACTOSAMINE PENTAACETATE
|
12167-39-4
|
C16H33NO15
|
|
|
8-(b-D-Galactopyranose)-octanoicacid
|
|
|
|
B-D-GALACTOPYRANOSEPENTAACETATE
|
|
C16H22O11
|
|
|
BDG BROTH, HAJNA
|
|
|
|
B-D-FLUCOSE AZIDE
|
|
C6H11N3O5
|
|
|
BCPP protocol
|
|
|
|
|
Bcp1 protein
|
|
|
|
|
BCP protocol
|
|
|
|
|
2BC protein, poliovirus
|
|
|
|
|
B2C protein
|
|
|
|
|
b-D-GlcNAc, 2-(2-Carboxyethylthio)-ethyl
|
|
|
|
b-D-Glucopyranose, 1,6-anhydro-2-azido-4-O-[2,3-bis-O-(phenylMethyl)-4,6-O-(phenylMethyl ene)-b-D-glucopyranosyl]-2-deoxy-, 3-acetate
|
99541-23-8
|
C35H37N3O10
|
|
b-D-Glucopyranoside, ethyl 1-thio-, 2,3,4,6-tetrabenzoate
|
113214-71-4
|
C36H32O9S
|
|
b-D-Glucopyranoside, ethyl 3-O-[(4-Methoxyphenyl)Methyl]-4,6-O-[(R)-phenylMethylene]-1-thio-, benzoate
|
151725-49-4
|
C30H32O7S
|
|
b-D-Glucopyranoside, 4-Methylphenyl 4,6-O-[(R)-(4-Methylphenyl)Methylene]-1-thio-, 2,3-dibenzoate
|
922523-06-6
|
C35H32O7S
|
|
b-D-Glucopyranoside, 4-Methylphenyl 6-O-[(4-Methoxyphenyl)Methyl]-2,3-bis-O-(phenylMethyl)-1-thio-
|
582322-06-3
|
C35H38O6S
|
|
b-D-Glucopyranoside, phenyl 3,4,6-tris-O-(phenylMethyl)-1-thio-
|
130781-27-0
|
C33H34O5S
|
|
b-D-Glucopyranose, 1-[3-(3,4-dihydroxyphenyl)-2-propenoate]
|
14364-08-0
|
C15H18O9
|
|
B-D-GLUCOSE 1-PHOSPHATE BIS(CYCLOHEXYLAM
|
14034-70-9
|
C12H26NO9P
|
|
6-(B-D-GLUCOPYRANOSYL)-7-(B-D-GLUCOPYRANOSYLOXY)-5-HYDROXY-2-(P-HYDROXYPHENYL)-4-CHROMENONE
|
|
C27H30O15
|
|
B-D-GLUCOPYRANOSE
|
60976-49-0
|
C41H28O27
|
|
2-(1-(B-D-GLUCOPYRANOSYLOXY)-1-METHYLETHYL)-2,3-DIHYDROFURO(3,2-G)CHROMEN-7-ONE
|
|
C20H24O9
|
|
8-(B-D-GLUCOPYRANOSYL)-5,7-DIHYDROXY-2-(P-HYDROXYPHENYL)-4-CHROMENONE
|
|
C21H20O10
|
|
b-D-Glucopyranosiduronic acid,(3b)-17-carboxy-28-norolean-12-en-3-yl
|
26020-14-4
|
C36H56O9
|
|
|
(1-3,1-4)-b-D-glucan
|
|
|
|
|
(1-3,1-4)-b-D-glucan hydrolase
|
|
|
|
B-D-Glucopyranoside,phenyl2,3-bis-O-(phenylmethyl)-4,6-O-[(R)-phenylmethylene]-1-thio-
|
87470-70-0
|
C33H32O5S
|
|
B-D-Glucopyranoside,4-methylphenyl6-O-[(1,1-dimethylethyl)diphenylsilyl]-2,3-bis-O-(phenylmethyl)-1-thio-
|
596087-20-6
|
C43H48O5SSi
|
|
B-D-Glucopyranose,1,6-anhydro-2-azido-2-deoxy-,3,4-diacetate
|
119005-80-0
|
C10H13N3O6
|
|
|
BCR/CRM-061 AQUATIC PLANT
|
|
|
|
|
BCR/CRM-150 SPIKED S MILK
|
|
|